Chronic Pain Prevalence, Characteristics, and Impact in United States Adults With Chronic Fatigue Syndrome/Myalgic Encephalomyelitis 2025 Adamowicz+

Andy

Senior Member (Voting rights)

Abstract​

Purpose​

To determine the prevalence of chronic pain, describe characteristics of chronic pain, and examine the impact of chronic pain on quality-of-life in United States adults with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).

Design​

Secondary analysis of cross-sectional data from the 2023 National Health Interview Survey.

Methods​

Survey weights and variance estimation variables were employed. Pain duration over the past 3 months was used to determine whether individuals with CFS/ME were experiencing chronic pain. Rao-Scott chi-square test examined group-based differences between those with CFS/ME and chronic pain to those with chronic pain without CFS/ME across pain characteristics (intensity, location, limitations) and three quality-of-life domains (psychological health, general health, life satisfaction).

Results​

The proportion of United States adults who reported having CFS/ME was 1.4% (weighted). Of those with CFS/ME, 70.7% (weighted) met study criteria for chronic pain. Pain was common across multiple body locations among those with comorbid CFS/ME and chronic pain, and impacted multiple domains of functioning, including life/work activities and family relationships. Relative to those with chronic pain without CFS/ME, individuals with CFS/ME and chronic pain were significantly more likely to have positive results on depression and anxiety screeners, and report fair/poor general health and life dissatisfaction (ps < .05).

Conclusions​

Chronic pain is common among individuals with CFS/ME and is associated with diminished quality-of-life. Although not all individuals with CFS/ME experience chronic pain, a prominent proportion do.

Clinical Implications​

For those with comorbid CFS/ME and chronic pain, interventions targeting the management of multiple symptoms may be particularly important.

Paywall
 
Well, at present there isn't any alternative to targeting multiple symptoms, since there is no treatment that reliably targets the disease. For that matter, there's no reliable treatment for any of the symptoms. Not safe ones, since I'm guessing that opioids are reliable at treating chronic pain, but not in a safe way that restores normal function.
 
Back
Top Bottom